About Breast Microseed Treatment®
Breast Microseed Treatment from Concure Oncology® is a proven method of radiation therapy for women with early-stage breast cancer following a lumpectomy. Using brachytherapy, Breast Microseed Treatment involves the precise placement of radioactive seeds in the breast that slowly release the prescribed dose safely over time. Microseed® radiation sources are implanted in and around the area where the tumor was removed, which is typically the area where cancer might recur.
Brachytherapy, also known as internal radiation, has proven to be an effective cancer treatment for decades, primarily with prostate cancer, but also with others, including cervical and skin cancers. The key to successful brachytherapy treatment is the precise placement of the radioactive sources. Using Computed Tomography (CT) imaging, the exact location of each seed is mapped out, then precisely inserted into the breast using ultrasound guidance.
This breast seed cancer treatment is particularly innovative because it treats early-stage breast cancer, which affects 1 in 8 women in North America. Early-stage breast cancer treated with lumpectomy, followed by radiation, historically yields the highest survival rates.
Breast Microseed Treatment has proven to be an effective type of breast cancer radiation in treating these early stage cancers, while offering patients a simpler, more convenient, less painful and less costly treatment option. Clinical studies utilizing 12 years of data in peer-reviewed, published articles report similar efficacy to other breast cancer radiation therapy techniques following a lumpectomy.
Not every patient is eligible for Breast Microseed Treatment. Consult your doctor to see if Breast Microseed Treatment is right for you.